QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T-cell response December 7, 2020December 9, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: The Lancet publishes studies showing Roche’s…New two-year data for Roche’s Vabysmo and Susvimo…New two-year data for Roche’s Vabysmo and Susvimo…The Lancet publishes studies showing Roche’s…Formation of Facial Structures: Using Light…FDA approves Roche’s Vabysmo, the first bispecific…